Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta
(2025)
Journal Article
Hald, J. D., Weir, C., Keerie, C., Dewar, L., MacLean, M., Milne, L., Keen, R., Walsh, J., Poole, K., Langdahl, B., Lindsay, J. R., Ghouri, N., Hollick, R. J., Aspray, T., Crowley, R. K., Cohen-Solal, M., Hassan-Smith, Z., Tuck, S., Curtis, E., …Ralston, S. H. (2025). Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta. Calcified Tissue International, 116(1), 136. https://doi.org/10.1007/s00223-025-01440-3
Introduction: Osteogenesis imperfecta (OI) is a rare disorder causing multiple fractures throughout life. No treatment has been shown to reduce the risk of fractures in OI. Here, we present the baseline characteristics of participants in the Treatmen... Read More about Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta.